|
|
||||||||||||||
|
|
|||||||||||||||
a Department
of Paediatrics, Lille University Hospital, Lille, France, b Department of Paediatrics, Dunkirk
City Hospital, Dunkirk, France, c Department
of Paediatrics, Camiers City Hospital, Camiers, France
Correspondence to: Professor D Turck, Service de Pédiatrie, Hôpital Huriez, 59037 Lille Cédex, France.
Accepted 21 November 1996
OBJECTIVE
To evaluate the short term effects on
nutritional status of home intravenous anti-pseudomonas antibiotic
courses in cystic fibrosis (CF) patients chronically colonised with
Pseudomonas aeruginosa.
DESIGN
A prospective study involving 38 CF
patients, mean age 10.9 (SD 4.3) years (range 4.3 to 22.2 years),
presenting with pulmonary exacerbations of P aeruginosa
infection. The patients received a 14 day antibiotic course of
intravenous ceftazidime (200 mg/kg/day) and either amikacin (35 mg/kg/day) or tobramycin (15 mg/kg/day). Nutritional evaluation on days
1 and 14 involved measurements of weight, weight/height ratio (per cent
of predicted value), energy intake (per cent of recommended daily
allowances), serum prealbumin, and body composition assessed by two
methods: bioelectrical analysis (BIA) and skinfold anthropometry. The
non-parametric Wilcoxon t test was used for statistical
analysis, with a Bland-Altman plot to assess the degree of agreement
between the two methods of evaluating body composition.
RESULTS
Weight increased by 1.0 (0.8) kg (p < 0.001); weight/height increased from 94.4(12.2)% to 98(12.7)% (p < 0.001), energy intake from 107(32)% to 119(41)% (p < 0.02), and
prealbumin from 183 (63) to 276 (89) mg/l (p < 0.001). Fat mass
increased by 0.8 (1.0) kg (p < 0.001), without any significant change
in fat-free mass. The limits of agreement between BIA and anthropometry
were -0.7 kg and +1.1 kg.
CONCLUSIONS
Antibiotic courses allow an
improvement in nutritional status in CF patients, with a gain in fat mass.
This article has been cited by other articles:
![]() |
I. Durieu, F. Abbas-Chorfa, J. Drai, J. Iwaz, J-P. Steghens, M. Puget, R. Ecochard, and G. Bellon Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Eur. Respir. J., May 1, 2007; 29(5): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
G L BRIARS, S A MCNAUGHTON, G J CLEGHORN, and R W SHEPHERD Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis Arch. Dis. Child., February 1, 1998; 78(2): 194b - 194. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |